Enterprise Value
314.6M
Cash
136.8M
Avg Qtr Burn
-25.82M
Short % of Float
5.02%
Insider Ownership
3.43%
Institutional Own.
85.48%
Qtr Updated
03/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
OTX-2002 Details Cancer, Hepatocellular carcinoma, Liver cancer | Phase 1/2 Data readout |